📋 Indications & Clinical Dosage
*Newly diagnosed glioblastoma multiforme in adults (in combination with radiotherapy) and subsequently as monotherapy, Second-line treatment of malignant glioma in adults:*
Adults: 150-200 mg/m2/day for 5 days, repeat every 28 days (consult product literature).
⚠️ Precautions & Warnings
Hepatic & renal impairment, elderly, risk of Pneumocystis jirovecii pneumonia; consult product literature for monitoring and prevention
⚠️ Adverse Reactions / Side Effects
Alopecia, bone-marrow suppression, hyperuricaemia, nausea, oral mucositis, Peripheral oedema thromboembolism, tumourlysis syndrome, vomiting
🤰 Pregnancy & Lactation Safety
Pregnancy Risk:
Positive evidence of risk: Avoid
Lactation / Breastfeeding:
Contraindicated. Discontinue breast-feeding